Beyer Research

Kalamazoo, Michigan 49009

0 studies enrolling now · 30 studies all time

What they study most

Chlamydia Trachomatis, Chronic Idiopathic Constipation, Contraception, Crohn's Disease, Cystitis, Interstitial, Dyspareunia, Episodic Migraine, Gonorrhea, Irritable Bowel Syndrome With Constipation, Menopause, Migraine, With or Without Aura, Nocturia

Studies at this site

• A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin) — Completed
• Study to Evaluate the Equivalence of Estradiol Vaginal Cream to Reference Standard in the Treatment of Vaginal Atrophy — Completed
• Study to Assess Long-Term Safety/Tolerability of Enobosarm (GTx 024) in Stress Urinary Incontinence — Withdrawn before enrolling
• Durability Extension Study to Assess Clinical Activity and Safety of Enobosarm (GTx-024) in Stress Urinary Incontinence — Withdrawn before enrolling
• Safety & Efficacy WC3011 (Estradiol Vaginal Cream) in the Treatment of Vulvovaginal Atrophy in Postmenopausal Women — Completed
• Evaluate Long-Term Safety and Efficacy WC3011 (Estradiol Vaginal Cream) — Completed
• A Trial to Investigate Efficacy, Safety and Tolerability of FE 201836 for Nocturia Due to Nocturnal Polyuria in Adults — Completed
• Restorelle® Mesh Versus Native Tissue Repair for Prolapse — Completed
• A Study To Investigate Tanezumab In Patients With Interstitial Cystitis/ Painful Bladder Syndrome — Stopped early
• Study to Evaluate the Safety and Tolerability of Treatment With Atogepant 60 mg Daily for the Prevention of Migraine in Participants With Episodic Migraine — Completed
• Xenform Postmarket Surveillance Study — Completed
• Study to Assess Enobosarm (GTx-024) in Postmenopausal Women With Stress Urinary Incontinence — Completed
• LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris — Completed
• Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone — Completed
• Evaluation of an Alternative Injection Paradigm for OnabotulinumtoxinA (BOTOX®) in the Treatment of Overactive Bladder in Patients With Urinary Incontinence — Completed
• An Open-Label, Long-term Study to Assess the Immunogenicity of LINZESS® (Linaclotide) Administered Orally to Adult Participants With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation — Completed
• Safety, Efficacy, Tolerability and Pharmacokinetics of LF111 (Drospirenone 4.0 mg) During 13 Cycles — Completed
• The Plecanatide Chronic Idiopathic Constipation (CIC) Study — Completed
• A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms — Completed
• Efficacy, Safety, and Tolerability Study of Oral Ubrogepant in the Acute Treatment of Migraine — Completed
• A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did Not Have Enough Response to the Medicine, Tolterodine. — Completed
• A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis With Hunner's Lesions — Completed
• A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome — Completed
• A Safety and Efficacy Study of Estradiol Vaginal Capsule in Postmenopausal Women With Vulvovaginal Atrophy — Completed
• Study Investigating the Impact Burden of Nocturia Using the Nocturia Impact Diary — Completed
• Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo — Completed
• Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women — Completed
• Phase II Proof of Concept Study in Uncomplicated UTI — Status unconfirmed
• Clinical Evaluation of the Aptima® Combo 2® Assay Using the Panther® System in Female Urine Samples — Stopped early
• Study Evaluating the Safety, Tolerability, and Efficacy of Dexmecamylamine (TC-5214) for Treatment of Overactive Bladder — Completed